Accompanied by representatives from GWG (Society for economic and urban development Goettingen), the mayor of Goettingen, Petra Broistedt, visited Bioventure.
Read more
Donation from Bioventure to UMG and Harzer Sonnenzwerge e.V. – support for children suffering from cancer
Read more
Bioventure invests as lead investor in PROVIREX Genome Editing Therapies GmbH, a Hamburg-based biotech company focusing on infectious diseases, primarily using a genome editing technology newly developed by its founders.
Read more
